BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6930152)

  • 1. Correlation between prognostic factors and blood variables in osteosarcoma.
    Broström LA; Ingimarsson S; Strander H; Eklund G
    Acta Med Scand; 1980; 207(5):429-31. PubMed ID: 6930152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients.
    Jettoo P; Tan G; Gerrand CH; Rankin KS
    J Orthop Surg (Hong Kong); 2019; 27(2):2309499019838293. PubMed ID: 30909848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
    Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
    Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of serum concentrations of biochemical bone turnover markers in patients with osteosarcoma with good and poor prognosis].
    Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
    Pol Merkur Lekarski; 2010 Jul; 29(169):19-26. PubMed ID: 20712242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment.
    Rychłowska-Pruszyńska M; Gajewska J; Ambroszkiewicz J; Karwacki M; Szamotulska K
    Dev Period Med; 2018; 22(1):58-64. PubMed ID: 29641422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
    Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
    Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
    Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
    Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary osteosarcoma in patients older than 40 years of age.
    Jeon DG; Lee SY; Cho WH; Song WS; Park JH
    J Korean Med Sci; 2006 Aug; 21(4):715-8. PubMed ID: 16891818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of blood analyses at relapse of osteosarcoma and Ewing's sarcoma.
    Hannisdal E; Solheim OP; Theodorsen L; Høst H
    Acta Oncol; 1990; 29(5):585-7. PubMed ID: 1976322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum isoenzymes of lactate dehydrogenase, esterase and alkaline phosphatase in several bone tumors].
    Surinov BP; Menzhinskaia GV
    Vopr Onkol; 1975; 21(5):23-6. PubMed ID: 1108434
    [No Abstract]   [Full Text] [Related]  

  • 12. [The behavior of some serum enzyme activities and electrophoretic pattern in patients with osseous neoplasms. Changes after treatment].
    Budroni G; Marogna L; Mundula A
    Arch Sci Med (Torino); 1968 May; 125(5):199-205. PubMed ID: 5246693
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognosis of osteosarcoma in Turkish adults.
    Seker MM; Seker A; Aksoy S; Ozdemir N; Uncu D; Zengin N
    Asian Pac J Cancer Prev; 2014; 15(8):3537-40. PubMed ID: 24870753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and haematological findings in malignant bone tumours.
    Brozmanová E; SKROVINA B
    Neoplasma; 1974; 21(1):75-82. PubMed ID: 4522900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Markers of bone formation in children with osteosarcoma].
    Gajewska J; Ambroszkiewicz J; Rychlowska-Pruszynska M; Laskowska-Klita T
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):235-43. PubMed ID: 15738599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs.
    Bacci G; Dallari D; Battistini A; Orlandi M; Ferrari S; Avella M; Picci P; Casadei R; Ruggieri P
    Chir Organi Mov; 1992; 77(2):171-80. PubMed ID: 1499384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro.
    Holmes KE; Thompson V; Piskun CM; Kohnken RA; Huelsmeyer MK; Fan TM; Stein TJ
    Vet Comp Oncol; 2015 Sep; 13(3):166-75. PubMed ID: 23489774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy.
    Thorpe WP; Reilly JJ; Rosenberg SA
    Cancer; 1979 Jun; 43(6):2178-81. PubMed ID: 287547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy.
    Chesi R; Cazzola A; Bacci G; Borghi B; Balladelli A; Urso G
    Cancer; 1989 Oct; 64(8):1727-37. PubMed ID: 2790686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.